Literature DB >> 4006143

Local changes in myosin types in diseased human atrial myocardium: a quantitative immunofluorescence study.

P Bouvagnet, J Léger, C A Dechesne, G Dureau, M Anoal, J J Léger.   

Abstract

Two monoclonal antibody groups were prepared from adult human atrial and ventricular myosin heavy chains. Using these two groups, we were able to identify two myosin variants in human atria and to classify human atrial fibers into alpha-, mixed, or beta-fibers according to the reactivity of the two monoclonal antibody groups to alpha- and beta-myosin heavy chains of normal young and hypothyroid rat ventricles, respectively. The alpha-fiber percentage of the left atria in two normal human hearts was 15% higher than in the right atria. The auricles contained two to three times more alpha-fibers than beta-fibers, whereas the proportion was reversed in the crista terminalis. The mean fiber diameter of the alpha- and beta-fibers was 13.6 +/- 3 micron. A complete alpha- to beta-fiber transition was observed in all atrial regions of two hearts with severe ventricular myocardial infarction; a moderate alpha- to beta-fiber transition was observed only in the left atria of two hearts with primary congestive cardiomyopathy. The mean diameters of the two fiber types were significantly increased in all diseased hearts (19 +/- 3.8 micron). We hypothesize that pressure overload and increased wall tension successively induce an enlargement of the fiber diameter and an alpha- to beta-myosin transition.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4006143     DOI: 10.1161/01.cir.72.2.272

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  9 in total

1.  Distribution pattern of alpha and beta myosin in normal and diseased human ventricular myocardium.

Authors:  P Bouvagnet; H Mairhofer; J O Leger; P Puech; J J Leger
Journal:  Basic Res Cardiol       Date:  1989 Jan-Feb       Impact factor: 17.165

2.  Ventricular myosin light chain 1 is developmentally regulated and does not change in hypertension.

Authors:  E M McNally; P M Buttrick; L A Leinwand
Journal:  Nucleic Acids Res       Date:  1989-04-11       Impact factor: 16.971

3.  Long-term expression of isomyosins and myoendocrine functions in ectopic grafts of atrial tissue.

Authors:  H Jockusch; E M Füchtbauer; A Füchtbauer; J J Leger; J Leger; C A Maldonado; W G Forssmann
Journal:  Proc Natl Acad Sci U S A       Date:  1986-10       Impact factor: 11.205

4.  Heterogeneity of beta-type myosin isozymes in the human heart and regulational mechanisms in their expression. Immunohistochemical study using monoclonal antibodies.

Authors:  H Tsuchimochi; M Kuro-o; H Koyama; M Kurabayashi; M Sugi; F Takaku; S Furuta; Y Yazaki
Journal:  J Clin Invest       Date:  1988-01       Impact factor: 14.808

5.  Calcium sensitivity and unloaded shortening velocity of hypertrophied and non-hypertrophied skinned human atrial fibres.

Authors:  H Arndt; C Bletz; H A Katus; G Mall; J C Rüegg
Journal:  Pflugers Arch       Date:  1989-11       Impact factor: 3.657

6.  Atrial and ventricular myosins from human hearts. II. Isoenzyme distribution after myocardial infarction.

Authors:  U Hoffmann; C Axmann; N Palm
Journal:  Basic Res Cardiol       Date:  1987 Jul-Aug       Impact factor: 17.165

7.  Cardiac beta myosin heavy chain diversity in normal and chronically hypertensive baboons.

Authors:  R D Henkel; J L VandeBerg; R E Shade; J J Leger; R A Walsh
Journal:  J Clin Invest       Date:  1989-05       Impact factor: 14.808

8.  Coexpression of alpha and beta myosin heavy-chain isoforms in atria of neonates and infants with congenital heart disease.

Authors:  H Milting; W R Thies; T Breymann; J Léger; J J Léger; H Meyer; R Körfer; H Jockusch
Journal:  Basic Res Cardiol       Date:  1993 Jul-Aug       Impact factor: 17.165

9.  Visualization of cardiac ventricular myosin heavy chain homodimers and heterodimers by monoclonal antibody epitope mapping.

Authors:  C A Dechesne; P Bouvagnet; D Walzthöny; J J Léger
Journal:  J Cell Biol       Date:  1987-12       Impact factor: 10.539

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.